The UK now sits on the brink of a critical judgment regarding AstraZeneca's proposed vaccine plant, with reports that the ruling administration will axe funds that will simply see this investment heading abroad. This article investigates why the UK has to win in securing this investment in order to get growth started for long-term benefits. …














